Hematology NewsMidostaurin maintenance may reduce relapse risk in FLT3-ITD+ AMLFebruary 25, 2019TransplantationAMLLeukemia, Myelodysplasia, TransplantationCellular Therapy
Hematology NewsZUMA-1 update: Axi-cel responses persist at 2 yearsFebruary 24, 2019B Cell LymphomaCellular TherapyTransplantationLymphoma & Plasma Cell DisordersImmuno-oncology
Hematology NewsDual-targeted CAR T shows ‘clinical signal’ in NHLFebruary 24, 2019B Cell LymphomaMantle Cell LymphomaCellular TherapyTransplantationLymphoma & Plasma Cell DisordersImmuno-oncology
Hematology NewsAlloBMT should be option for older adults with hematologic malignanciesFebruary 24, 2019TransplantationCellular Therapy
Hematology NewsMRD negativity linked to survival in MM after auto-HCTFebruary 24, 2019TransplantationMultiple MyelomaCellular TherapyLymphoma & Plasma Cell Disorders
Hematology NewsAnti-GM-CSF antibody reduced CAR T-cell toxicityFebruary 24, 2019TransplantationCellular TherapyTranslational ResearchImmuno-oncology
Hematology NewsTreosulfan may become standard in allo-HCT for AML/MDSFebruary 23, 2019TransplantationCellular TherapyAMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsUltrasound method predicts liver complications in pediatric transplantFebruary 23, 2019TransplantationPediatricsCellular Therapy
Hematology NewsHaplo-HCT shows viability in DLBCLFebruary 21, 2019B Cell LymphomaCellular TherapyLymphoma & Plasma Cell DisordersTransplantation
Oncology PracticeCMS proposes coverage of CAR T-cell therapy in trialsFebruary 15, 2019Practice ManagementBusiness of MedicineTransplantationImmuno-oncologyImmunotherapyGene Therapy
Hematology NewsPD-1 blockade plus CD19 CAR T boosts CAR T-cell persistenceFebruary 8, 2019ALLPediatricsLeukemia, Myelodysplasia, TransplantationImmuno-oncologyCellular TherapyTransplantation
Hematology NewsNovel bispecific CAR shows promise in B-cell malignanciesJanuary 25, 2019Aggressive LymphomasCellular TherapyLymphoma & Plasma Cell DisordersTransplantationImmuno-oncologyImmunotherapyB Cell Lymphoma
Hematology TimesGroup proposes new grading systems for CRS, neurotoxicityJanuary 3, 2019Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCHMP recommends treosulfan for allo-HSCT conditioningDecember 21, 2018PharmacyTransplantation
